Trial Profile
An open label randomised study comparing the role of combination of everolimus and low dose tacrolimus with full dose tacrolimus in the prevention of left ventricular hypertrophy in heart transplant recepients.
Status:
Not yet recruiting
Phase of Trial:
Phase 0
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate; Prednisolone; Tacrolimus
- Indications Left ventricular hypertrophy
- Focus Therapeutic Use
- Acronyms RAD-TAC
- 25 Jul 2014 New trial record